Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for padeliporfin vascular-targeted photodynamic therapy in locally advanced unresectable pancreatic adenocarcinoma; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Padeliporfin VTP (padeliporfin)

Snippet

Sponsor: Impact Biotech Ltd | Conditions: Locally Advanced Unresectable Pancreatic Adenocarcinoma | Phase 1 | Status: RECRUITING